ClinicalTrialsFinder

Recurrent Oropharyngeal Carcinoma Clinical Trials in Rochester, Minnesota

1 recruitingRochester, Minnesota

Showing 1–1 of 1 trials

Recruiting
Phase 2

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Head and Neck CancerOropharynx CancerClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+15 more
Mayo Clinic25 enrolled1 locationNCT06997068